Status:
COMPLETED
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
Lead Sponsor:
Mclean Hospital
Conditions:
Social Anxiety Disorder
Specific Phobia
Eligibility:
All Genders
6-19 years
Phase:
NA
Brief Summary
The collection of patient self-report and diagnostic data will allow us to examine the efficacy of the treatment delivered in the McLean Anxiety Mastery Program. Using data gathered through routine cl...
Detailed Description
The study population will involve all assenting/consenting patients, both male and female, admitted to the McLean Anxiety Mastery Program at McLean Hospital. This program provides intensive group-base...
Eligibility Criteria
Inclusion
- All youth who are eligible to participate in the McLean Anxiety Mastery Program will be invited to participate in the research study.
- Eligibility criteria for the McLean Anxiety Mastery Program include:
- children and adolescents who are between the ages of 6 and 19 and
- who present with at least one of the following disorders:
- Separation Anxiety Disorder,
- Social Anxiety Disorder,
- Panic Disorder,
- Agoraphobia,
- Specific Phobia(s), and
- OCD.
- Interested and eligible patients and their caregivers should complete and submit an application (https://www.mcleanhospital.org/sites/default/files/2021-07/MAMP-Application-07032021\_0.pdf) to begin the phone screen process.
Exclusion
- Patients ineligible for the treatment program, and therefore the study, include those who have engaged in substance abuse during the six weeks prior to the first evaluation (i.e., waitlist or admission) the phone screening,
- those who report that they are unwilling to refrain from self-injurious behaviors during the waitlist and treatment periods,
- those who are experiencing active symptoms of psychosis,
- those who exhibit severe behavioral disinhibition or aggression, and
- those who express an intent and/or plan to commit suicide or homicide at the time of their first evaluation the initial phone screening.
- Patients must be fluent in English to participate in the program because all off-grounds exposure groups will be conducted in English (whenever possible, however, translation services will be provided for patients whose parents are not fluent in English).
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
559 Patients enrolled
Trial Details
Trial ID
NCT02305537
Start Date
October 1 2014
End Date
November 1 2024
Last Update
October 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Cambridge, Massachusetts, United States, 02138